We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Handheld Device Aids Diagnosis of Skin Cancer

By MedImaging International staff writers
Posted on 01 Jul 2019
Print article
Image: Reflectivity patterns can distinguish between basal cell carcinoma (L) and squamous cell carcinoma (R) (Photo courtesy of Stevens Institute of Technology).
Image: Reflectivity patterns can distinguish between basal cell carcinoma (L) and squamous cell carcinoma (R) (Photo courtesy of Stevens Institute of Technology).
A new study shows how ultra-high-resolution millimeter-wave imaging (UH-MMWI) can be used to detects skin lesions and determine if they are cancerous or benign.

Developed by researchers at the Stevens Institute of Technology (Hoboken, NJ, USA) and Hackensack University Medical Center (NJ, USA), the new technology can realize three-dimensional (3D) high-contrast images of the skin by taking advantage of intrinsic dielectric contrasts between normal and malignant skin tissues. The system works in the 98 GHz bandwidth, which is also used in cellphones and airport security scanners. As cancerous tumors reflect around 40% more calibrated energy than healthy tissue, it is possible to identify diseased tissue by searching for reflectivity hotspots.

A programmable measurement platform automatically scan the tissues across a rectangular aperture plane, while a frequency domain imaging algorithm processes the recorded signals and generates an image of the cancerous tissue. To test the device, the researchers imaged 21 non-melanoma skin cancer specimens and compared them with histopathology. The results revealed a high correlation between MMWI and histological images, with reflectivity values statistically significant higher for cancerous areas compared to normal areas. The study was published on March 4, 2019, in IEEE Transactions on Medical Imaging.

“This technology can be used for rapidly detecting skin cancer. That's a major step forward toward our ultimate goal of developing a handheld device, which would be safe to use directly on the skin for an almost instant diagnostic reading of specific kinds of skin cancer, including lethal melanomas,” said senior author Negar Tavassolian, PhD, director of the Stevens Bio-Electromagnetics Laboratory. “We could place these devices in pharmacies, so people can get checked out and go to a doctor for a follow-up if necessary. People won't need to wait weeks to get results, and that will save lives.”

According to the researchers, it should be possible to keep manufacturing costs below USD 1,000, even at low production volumes, which is similar to the cost of current optical magnifying tools already used by dermatologists, and an order of magnitude cheaper than laser-based imaging tools, which also tend to be slower, bulkier, and less accurate than millimeter-wave scanners.

Related Links:
Stevens Institute of Technology
Hackensack University Medical Center

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Thyroid Shield
Standard Thyroid Shield
PACS Workstation
CHILI Web Viewer
Ultrasound Needle Guide
Ultra-Pro II

Print article

Channels

Ultrasound

view channel
Image: The AI-powered Point Of Care Assisted Diagnosis (POCAD) solution is transforming the medical ultrasound industry (Photo courtesy of AISAP)

First AI-Powered POC Ultrasound Diagnostic Solution Helps Prioritize Cases Based On Severity

Ultrasound scans are essential for identifying and diagnosing various medical conditions, but often, patients must wait weeks or months for results due to a shortage of qualified medical professionals... Read more

Nuclear Medicine

view channel
Image: Whole-body maximum-intensity projections over time after [68Ga]Ga-DPI-4452 administration (Photo courtesy of SNMMI)

New PET Agent Rapidly and Accurately Visualizes Lesions in Clear Cell Renal Cell Carcinoma Patients

Clear cell renal cell cancer (ccRCC) represents 70-80% of renal cell carcinoma cases. While localized disease can be effectively treated with surgery and ablative therapies, one-third of patients either... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more